In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Friday, 5:10 AM

April 3, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Pam Bondi Out

Pam Bondi was fired as U.S. Attorney General by President Trump after 14 months in office.

Trump grew frustrated with her slow action on his agenda and failure to aggressively prosecute political opponents; key cases against James Comey and Letitia James were dismissed.

Bondi also faced criticism for closing the Jeffrey Epstein investigation in July 2025 after releasing heavily redacted documents, prompting new disclosure laws. Attempts to appease Trump, including appointing a 2020 election fraud prosecutor, failed.

Her firing follows the recent dismissal of Homeland Security Secretary Kristi Noem.

Sources: WallStreetJournal, AP News, Reuters

Iran’s War Kids

The U.S. deployed thousands of Marines and Airborne troops to the Middle East, prompting Iran to bolster defenses on Kharg Island with missiles, mines, and booby traps.

The IRGC launched a campaign recruiting children as young as 12 into Basij militias, with videos and eyewitnesses confirming armed minors at checkpoints and rallies.

Iran’s laws permit under-15 enlistment with financial incentives, violating international law banning child soldiers. Since escalation, Iran reported 1,900+ deaths, including 216 children.

Iran’s 1 million-strong forces rely on asymmetric tactics, threatening to target Gulf oil infrastructure if invaded, warning of heavy U.S. casualties.

Sources: WallStreetJournal, Amnesty, Nypost

Private Credit Exodus

So far in 2026, investors have withdrawn nearly $14 billion from private-credit funds, more than doubling last quarter’s $5.7 billion and rising sharply from 2024’s $3.7 billion total.

Blue Owl Capital faced $5.4 billion in redemptions in Q1, including 22% from its flagship fund. Other firms like Apollo, Blackstone, and BlackRock also exceeded 5% quarterly redemption limits, leaving billions trapped.

Private-credit funds, primarily lending to junk-rated firms through BDCs, face rising loan defaults and deferred interest—8% of BDC interest income was deferred in 2025, double 2019 levels.

Blue Owl reported losses and stock prices for key firms fell sharply. Despite $43 billion raised in 2025, elevated redemptions and liquidity risks remain.

Sources: WallStreetJournal, Bloomberg, Reuters

Liberation Day

President Trump imposed a 100% tariff on branded pharmaceutical imports without U.S. production or price cuts; partial U.S. production leads to a 20% tariff.

Imports from the EU, Japan, South Korea, and Switzerland are capped at 15%, while British drugs have zero tariffs for three years. Large drug firms have 120 days to comply, smaller ones 180.

Tariffs on steel, aluminum, and copper derivatives were cut to 25%, with less than 15% metal-content products now tariff-free. Commodity metals maintain a 50% duty based on U.S. sales price.

Tariffs on metal-heavy industrial equipment drop to 15% through 2027. These follow the Supreme Court’s rejection of Trump’s previous broad tariffs, prompting a $166 billion refund plan. Business groups are divided in response.

Sources: Reuters, AP News

Death’s Footprints

Researchers identified a new extracellular vesicle, F-ApoEVs, that marks sites of cell death and directs immune cells to clear debris, preventing inflammation. Cell death is an organized process involving these vesicles.

Viruses like influenza can hide inside F-ApoEVs, potentially spreading infection by exploiting immune cleanup. The study reveals ongoing cell-to-cell communication after death and suggests new therapeutic targets for infectious and autoimmune diseases.

Understanding F-ApoEVs may lead to drugs that enhance immune function and treatment outcomes. The research was conducted at La Trobe University with collaborators and published in Nature Communications in October 2025.

Sources: SciTechDaily

Megadelic Plant

Scientists engineered Nicotiana benthamiana tobacco plants to produce five psychedelics simultaneously: DMT, psilocin, psilocybin, bufotenin, and 5-MeO-DMT.

They combined genes from plants, a mushroom, a toad, and enzymes from rice and cress. Production levels varied but showed potential for optimization.

Researchers also created novel psychedelic compounds by modifying enzymes, which may have therapeutic uses. This plant-based method offers a sustainable alternative to harvesting natural sources and provides a platform for producing and studying psychoactive tryptamines.

The work could advance treatments for depression, anxiety, and PTSD while reducing ecological impact.

Sources: Sciencealert

“The things of this world are exactly like your own shadow: chase it, and it outruns you every time; turn around and walk away, and it will follow right at your heels.”

Baked with love,

Anna Eisenberg ❤️

*Terms & Conditions apply. Not available if with Metro in the last 180 days. If using >35GB/mo. May notice

*Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product. Compounded medications are not reviewed by the FDA for safety, efficacy, or quality.